Literature DB >> 25799158

Volume of Distribution in Drug Design.

Dennis A Smith1, Kevin Beaumont2, Tristan S Maurer2, Li Di3.   

Abstract

Volume of distribution is one of the most important pharmacokinetic properties of a drug candidate. It is a major determinant of half-life and dosing frequency of a drug. For a similar log P, a basic molecule will tend to exhibit higher volume of distribution than a neutral molecule. Acids often exhibit low volumes of distribution. Although a design strategy against volume of distribution can be advantageous in achieving desirable dosing regimen, it must be well-directed in order to avoid detrimental effects to other important properties. Strategies to increase volume of distribution include adding lipophilicity and introducing basic functional groups in a way that does not increase metabolic clearance.

Mesh:

Year:  2015        PMID: 25799158     DOI: 10.1021/acs.jmedchem.5b00201

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  38 in total

1.  Design of Potent and Orally Active GPR119 Agonists for the Treatment of Type II Diabetes.

Authors:  Ping Liu; Zhiyong Hu; Byron G DuBois; Christopher R Moyes; David N Hunter; Cheng Zhu; Nam Fung Kar; Yuping Zhu; Joie Garfunkle; Ling Kang; Gary Chicchi; Anka Ehrhardt; Andrea Woods; Toru Seo; Morgan Woods; Margaret van Heek; Karen H Dingley; Jianmei Pang; Gino M Salituro; Joyce Powell; Jenna L Terebetski; Viktor Hornak; Louis-Charles Campeau; Joe Lamberson; Fez Ujjainwalla; Michael Miller; Andrew Stamford; Harold B Wood; Timothy Kowalski; Ravi P Nargund; Scott D Edmondson
Journal:  ACS Med Chem Lett       Date:  2015-07-10       Impact factor: 4.345

2.  Late-Stage Functionalization of Platensimycin Leading to Multiple Analogues with Improved Antibacterial Activity in Vitro and in Vivo.

Authors:  Youchao Deng; Xiang Weng; Yuling Li; Meng Su; Zhongqing Wen; Xinxin Ji; Nan Ren; Ben Shen; Yanwen Duan; Yong Huang
Journal:  J Med Chem       Date:  2019-07-02       Impact factor: 7.446

3.  In Vitro Efficacies, ADME, and Pharmacokinetic Properties of Phenoxazine Derivatives Active against Mycobacterium tuberculosis.

Authors:  Lloyd Tanner; Joanna C Evans; Ronnett Seldon; Audrey Jordaan; Digby F Warner; Richard K Haynes; Christopher J Parkinson; Lubbe Wiesner
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

4.  Utility of Physicochemical Properties for the Prediction of Toxicological Outcomes: Takeda Perspective.

Authors:  Tomoya Yukawa; Russell Naven
Journal:  ACS Med Chem Lett       Date:  2020-01-29       Impact factor: 4.345

5.  Strategy for Extending Half-life in Drug Design and Its Significance.

Authors:  Hakan Gunaydin; Michael D Altman; J Michael Ellis; Peter Fuller; Scott A Johnson; Brian Lahue; Blair Lapointe
Journal:  ACS Med Chem Lett       Date:  2018-04-02       Impact factor: 4.345

6.  Why Decreasing Lipophilicity Alone Is Often Not a Reliable Strategy for Extending IV Half-life.

Authors:  Fabio Broccatelli; Ignacio Aliagas; Hao Zheng
Journal:  ACS Med Chem Lett       Date:  2018-04-19       Impact factor: 4.345

7.  2D-SAR and 3D-QSAR analyses for acetylcholinesterase inhibitors.

Authors:  Bing Niu; Manman Zhao; Qiang Su; Mengying Zhang; Wei Lv; Qin Chen; Fuxue Chen; Dechang Chu; Dongshu Du; Yuhui Zhang
Journal:  Mol Divers       Date:  2017-03-09       Impact factor: 2.943

8.  Projecting ADME Behavior and Drug-Drug Interactions in Early Discovery and Development: Application of the Extended Clearance Classification System.

Authors:  Ayman F El-Kattan; Manthena V Varma; Stefan J Steyn; Dennis O Scott; Tristan S Maurer; Arthur Bergman
Journal:  Pharm Res       Date:  2016-09-12       Impact factor: 4.200

9.  Discovery of Piperazinylquinoline Derivatives as Novel Respiratory Syncytial Virus Fusion Inhibitors.

Authors:  Xiufang Zheng; Lisha Wang; Baoxia Wang; Kun Miao; Kunlun Xiang; Song Feng; Lu Gao; Hong C Shen; Hongying Yun
Journal:  ACS Med Chem Lett       Date:  2016-04-20       Impact factor: 4.345

10.  Mithramycin 2'-Oximes with Improved Selectivity, Pharmacokinetics, and Ewing Sarcoma Antitumor Efficacy.

Authors:  Yang Liu; Joseph M Eckenrode; Yinan Zhang; Jianjun Zhang; Reiya C Hayden; Annet Kyomuhangi; Larissa V Ponomareva; Zheng Cui; Jürgen Rohr; Oleg V Tsodikov; Steven G Van Lanen; Khaled A Shaaban; Markos Leggas; Jon S Thorson
Journal:  J Med Chem       Date:  2020-11-16       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.